ENSC
Ensysce Biosciences, Inc.
Set alert
0.42 USD -0.02 -3.88%
0.42 Day range 0.44
0.251 52-week range 2.18
- YTD
- -54.24%
- 1 year
- -80.51%
- Open
- 0.427
- Prev close
- 0.438
- Mkt cap
- 8.19M
- Vol
- 108.95K
- Avg vol
- 13.97M
- EPS
- -2.47
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.42
- High
- 0.44
- Forward P/E
- -9.08
- Beta
- 0.64
- Short ratio
- 0.12
- Inst. own
- 22.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 7.25
- 200-d avg
- 7.64
- 1y target
- 102.00
Financial health
Altman Z-Score
-82.02 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.2×
FY 2017 5y median -1.8× FY 2025
P/S 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 0.7×
FY 2017 5y median -6.5× FY 2025
P/FCF -0.3×
FY 2017 5y median -1.9× FY 2025
EV/EBITDA 0.2×
FY 2017 5y median -1.6× FY 2025
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -337.1%
FY 2017 5y median -52.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -316.6%
FY 2017 5y median 369.2% FY 2025
ROIC -320.9%
FY 2017 5y median -320.9% FY 2025
ROA -136.5%
FY 2017 5y median -177.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -52.2%
FY 2017 FY 2025
EPS (diluted) 12.9%
FY 2017 FY 2025
Free Cash Flow -5.7%
FY 2017 FY 2025
Financial Health
Current Ratio 1.6×
FY 2017 5y median 1.0× FY 2025
Quick Ratio 1.6×
FY 2017 5y median 1.0× FY 2025
Debt / Equity 0.1×
FY 2017 5y median -1.2× FY 2025
Net Debt / EBITDA 0.4×
FY 2017 5y median 0.0× FY 2025
Interest Coverage -546×
FY 2017 5y median -30.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31